Fludrocortisone as Add-On May Boost Onset of SSRI

ISTANBUL, TURKEY — Stimulating brain mineralocorticoid receptors with fludrocortisone as add-on therapy to escitalopram for major depression significantly accelerated the antidepressant response in a randomized, double-blind, placebo-controlled proof-of-concept study.